Aclaris Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-88.48	-86.91	-90.87	-51.02	-161.35	-132.74	-68.52	-48.08	-23.13	-10.57	Upgrade
Depreciation & Amortization	0.86	0.8	0.92	1.32	6.41	1.88	0.4	0.12	0.09	0.01	Upgrade
Share-Based Compensation	20.54	15.04	14.06	11.21	16.18	20.06	14.43	6.1	0.89	0.03	Upgrade
Other Operating Activities	-11.25	3.51	23.75	-0.15	42.32	9.99	-0.97	7.25	-0.79	0.84	Upgrade
Operating Cash Flow	-78.33	-67.57	-52.13	-38.63	-96.45	-100.81	-54.66	-34.6	-20.37	-7.64	Upgrade
Capital Expenditures	-1.31	-0.61	-0.31	-0.45	-1.61	-1.36	-1.24	-0.23	-0.51	-0.42	Upgrade
Acquisitions	0	0	0	0	34.19	-67.12	-9.65	0	0	0	Upgrade
Change in Investments	47.53	13.23	-167.32	6.84	73.11	77.85	-44.81	-61.67	-76.44	-1.36	Upgrade
Investing Cash Flow	46.22	12.63	-167.63	6.39	105.68	9.37	-55.69	-61.9	-76.95	-1.78	Upgrade
Share Issuance / Repurchase	26.81	72.9	239.66	7.81	0.21	100.78	100.46	116.83	56.55	0	Upgrade
Debt Issued / Paid	0	0	-11.48	10.78	-30.52	29.26	-0.08	0	0	0	Upgrade
Other Financing Activities	-0.1	-0.03	-3.12	-0.21	-	-1.78	-	-	39.86	10.58	Upgrade
Financing Cash Flow	26.71	72.87	225.05	18.37	-30.32	128.26	100.39	116.83	96.41	10.58	Upgrade
Net Cash Flow	-5.4	17.93	5.29	-13.87	-21.08	36.82	-9.97	20.32	-0.91	1.17	Upgrade
Free Cash Flow	-79.63	-68.17	-52.44	-39.09	-98.06	-102.17	-55.9	-34.84	-20.88	-8.05	Upgrade
Free Cash Flow Margin	-254.84%	-229.13%	-775.65%	-602.99%	-2319.80%	-1660.98%	-3321.33%	-	-	-	Upgrade
Free Cash Flow Per Share	-1.14	-1.04	-0.92	-0.92	-2.37	-3.10	-1.99	-1.63	-3.42	-4.68	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).